Should a primary prostatic cancer show PSMA-expression, a PSMA+ and PSMA- finding will be characterized as secondary lesion or treated as unimportant/benign lesion respectively in the fragment of an imaging technic with high negative predictive value (16). The gene discussed is FOLH1; the disease is Familial prostate cancer.